CareFirst BlueCross BlueShield (CareFirst) and Exagen Diagnostics, Inc. (Exagen), a leading Rheumatology specialty life sciences company, today announced an agreement to collaborate to study the impact of Exagen’s proprietary AVISE Lupus test. As part of the agreement, select CareFirst members will have access to the AVISE Lupus test to aid in the differential diagnosis of systemic lupus erythematosus (SLE). ... |